相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Recombinant Virus SARS-CoV-2 Nucleocapsid protein
- 形态:
liquid
- 保存条件:
见COA
- 克隆性:
单克隆
- 保质期:
见COA
- 库存:
大量
- 供应商:
北京辰辉创聚生物技术有限公司
- 应用范围:
ELISA
- 抗体英文名:
Anti-SARS-CoV-2 Nucleocapsid Monoclonal Antibody
- 抗体名:
抗SARS-CoV-2 Nucleocapsid 单抗
- 规格:
100ul; 500ul; 1ml

| 产品信息
品名:NebuSelect™ Anti-SARS-CoV-2 Nucleocapsid Monoclonal Antibody
别名:2019-nCoV N Protein
货号:NBAB-189666
品牌:辰辉创聚生物®️
规格:100ul; 500ul; 1ml
| 产品描述
NebuSelect™ Anti-SARS-CoV-2 Nucleocapsid Monoclonal Antibody (Cat# NBAB-189666) was produced in Rabbit immunized with Recombinant Virus SARS-CoV-2 Nucleocapsid protein, and it reacts with Virus. This antibody is validated for ELISA.
| 产品属性
Product Category:Recombinant Antibody
Reactivity:Virus
Specificity:Virus SARS-CoV-2 Nucleocapsid
Immunogen:Recombinant Virus SARS-CoV-2 Nucleocapsid protein
Isotype:Recombinant Rabbit IgG
Purification:Protein A & Protein G Affinity Purification
Buffer:0.2 μm filtered solution in PBS, pH7.4, containing 0.09% Sodium azide, 50% glycerol.
Conjugate:Unconjugated
Applications:ELISA
Dilution:ELISA 1:2000~1:10000
Storage:This liquid antibody can be stored at 2℃-8℃ for at least two weeks. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or antibody diluent, the antibody is stable for at least two weeks at 2-4℃.
For Research Use Only!
To get more information, please contact us freely.
郑重声明:仅用于科学研究,不可用于诊断或治疗。
更多产品细节,请联系我司相关客服人员。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Cell Death Differ:中大五院黄曦团队发现新冠病毒引起肺损伤的分子机制
近期,中山大学附属第五医院黄曦团队报道了 SARS-CoV-2 的 membrane (M) 蛋白通过靶向并抑制胞内 BOK 的泛素化降解,激活肺上皮细胞线粒体凋亡途径而引起肺损伤,该发现为 COVID-19 的靶向治疗提供了潜在靶点。 图片来源:Cell death & differentiation SARS-CoV-2 感染已经导致全球数以百万人的死亡,其中大部分死亡患者出现呼吸困难,肺部出现大量凋亡的细胞和渗漏的粘液,已有研究证实 SARS-CoV-2 感染引起肺细胞凋亡参与上述
Establishment and Characterization of Monoclonal Antibodies Against SARS Coronavirus
to have in vitro neutralization activity. Thus the monoclonal antibody approach provides useful tools for rapid and specific diagnosis of SARS, as well as for possible antibody-based treatment of the disease.
医学生理病理与临床分册2000,20(2):137-140.[5]Yang XD,Jia XC,Corvalan JR, etal.Development of ABX-EGF,a fully human anti-EGF receptor monoclonal antibody,forcancertherapy.Hematology, 2001,38:17-13.[6]Herbst RS,langer CJ.Epidermal growth factor receptors as a target
技术资料暂无技术资料 索取技术资料







